HER2 gene copy number status may influence clinical efficacy to anti-EGFR monoclonal antibodies in metastatic colorectal cancer patients

BACKGROUND: In metastatic colorectal cancer (mCRC), KRAS is the only validated biomarker used to select patients for administration of epidermal growth factor receptor (EGFR)-targeted therapies. To identify additional predictive markers, we investigated the importance of HER2, the primary EGFR dimer...

Descripción completa

Detalles Bibliográficos
Autores principales: Martin, V, Landi, L, Molinari, F, Fountzilas, G, Geva, R, Riva, A, Saletti, P, De Dosso, S, Spitale, A, Tejpar, S, Kalogeras, K T, Mazzucchelli, L, Frattini, M, Cappuzzo, F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3593567/
https://www.ncbi.nlm.nih.gov/pubmed/23348520
http://dx.doi.org/10.1038/bjc.2013.4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3593567/
https://www.ncbi.nlm.nih.gov/pubmed/23348520
http://dx.doi.org/10.1038/bjc.2013.4

Ejemplares similares